LITTLE KNOWN FACTS ABOUT NKP608.

), assists to clarify why KIF15 is able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by the two of such mitotic motors was arrested only once they were being separately inhibited, lending assist on the proposal that a mix drug therapy targeting these motors may be a workable tactic for beating chemotherapeutic resistance to